MHRA Issues Guidance on Marketing Biologics in No-Deal Brexit

Drug Industry Daily
The MHRA’s National Institute for Biological Standards and Control (NIBSC) released guidance in anticipation of a no-deal Brexit on March 29, including a flow chart biologic drugmakers can use to determine if their batches require UK certification.

To View This Article:


Subscribe To Drug Industry Daily